This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Allgenesis Biotherapeutics Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Yesudoss Christu Rajan: Innovator in Pharmaceutical Compounds
Introduction
Yesudoss Christu Rajan is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as BACE1 inhibitors. His work aims to address various cognitive disorders and diseases, showcasing his commitment to advancing medical science.
Latest Patents
Yesudoss holds a patent for "Compounds and their use as BACE1 inhibitors." This invention relates to specific compounds of Formula (I) or their stereoisomers, tautomers, or pharmaceutically acceptable salts or solvates. The patent outlines a pharmaceutical composition that includes these compounds and describes therapeutic methods for treating and preventing conditions such as Down syndrome, Alzheimer's disease, and other neurodegenerative disorders. His innovative approach has the potential to impact the treatment of cognitive impairments and related diseases significantly.
Career Highlights
Currently, Yesudoss is associated with Allgenesis Biotherapeutics Inc., where he continues to work on groundbreaking research in the pharmaceutical sector. His expertise and dedication have positioned him as a valuable asset in the field of biotherapeutics.
Collaborations
Yesudoss collaborates with esteemed colleagues, including Richard Beresis and Hsiao-Wen Lin. These partnerships enhance the research and development efforts at Allgenesis Biotherapeutics Inc., fostering an environment of innovation and discovery.
Conclusion
Yesudoss Christu Rajan's contributions to pharmaceutical innovations, particularly in the realm of cognitive disorder treatments, highlight his role as a leading inventor. His work not only advances scientific knowledge but also holds promise for improving the quality of life for individuals affected by these conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile